155 related articles for article (PubMed ID: 7589222)
21. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
Barton CL; Hutson PH
Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
[TBL] [Abstract][Full Text] [Related]
22. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
Dawson LA; Li P
J Neural Transm (Vienna); 2003 Jun; 110(6):577-90. PubMed ID: 12768354
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the biphasic blood pressure response to alpha-methyl-5-hydroxytryptamine in anaesthetized rats.
Balasubramaniam G; Lee HS; Mah SC
Arch Int Pharmacodyn Ther; 1995; 329(3):360-78. PubMed ID: 8546536
[TBL] [Abstract][Full Text] [Related]
24. 5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination.
Goodnough DB; Baker GB
J Neurochem; 1994 Jun; 62(6):2262-8. PubMed ID: 8189233
[TBL] [Abstract][Full Text] [Related]
25. Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig.
Cadogan AK; Marsden CA; Tulloch I; Kendall DA
Neuropharmacology; 1993 Mar; 32(3):249-56. PubMed ID: 8386340
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist.
Rinaldi-Carmona M; Bouaboula M; Congy C; Oury-Donat F; Simiand J; Shire D; Casellas P; Soubrié P; Brelière JC; Le Fur G
Eur J Pharmacol; 1993 Jun; 246(1):73-80. PubMed ID: 8354344
[TBL] [Abstract][Full Text] [Related]
27. Agonist induced-phosphorylation of Galpha11 protein reduces coupling to 5-HT2A receptors.
Shi J; Damjanoska KJ; Singh RK; Carrasco GA; Garcia F; Grippo AJ; Landry M; Sullivan NR; Battaglia G; Muma NA
J Pharmacol Exp Ther; 2007 Oct; 323(1):248-56. PubMed ID: 17646429
[TBL] [Abstract][Full Text] [Related]
28. (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex.
Edwards E; Ashby CR; Wang RY
Neuropharmacology; 1992 Jul; 31(7):615-21. PubMed ID: 1407401
[TBL] [Abstract][Full Text] [Related]
29. Holtzman and Harlan Sprague-Dawley rats: differences in DRL 72-sec performance and 8-hydroxy-di-propylamino tetralin-induced hypothermia.
Balcells-Olivero M; Cousins MS; Seiden LS
J Pharmacol Exp Ther; 1998 Aug; 286(2):742-52. PubMed ID: 9694929
[TBL] [Abstract][Full Text] [Related]
30. Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine.
Berendsen HH; Broekkamp CL
Psychopharmacology (Berl); 1997 Oct; 133(3):275-82. PubMed ID: 9361334
[TBL] [Abstract][Full Text] [Related]
31. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
Kramer HK; Poblete JC; Azmitia EC
Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
[TBL] [Abstract][Full Text] [Related]
32. Selective heterologous regulation of 5-HT1A receptor-stimulated 35S GTPgammaS binding in the anterior cingulate cortex as a result of 5-HT2 receptor activation.
Valdez M; Burke TF; Hensler JG
Brain Res; 2002 Dec; 957(1):174-82. PubMed ID: 12443993
[TBL] [Abstract][Full Text] [Related]
33. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
[TBL] [Abstract][Full Text] [Related]
34. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
Mitchell SN; Greenslade RG; Cooper J
Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
[TBL] [Abstract][Full Text] [Related]
35. Role of central 5-HT(2) receptors in fluoxetine-induced decreases in T lymphocyte activity.
Pellegrino TC; Bayer BM
Brain Behav Immun; 2002 Apr; 16(2):87-103. PubMed ID: 11908920
[TBL] [Abstract][Full Text] [Related]
36. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
[TBL] [Abstract][Full Text] [Related]
37. Rats selectively bred for responsiveness to 5-hydroxytryptamine(1A) receptor stimulation: differences in differential reinforcement of low rate 72-second performance and response to serotonergic drugs.
Cousins MS; Vosmer G; Overstreet DH; Seiden LS
J Pharmacol Exp Ther; 2000 Jan; 292(1):104-13. PubMed ID: 10604936
[TBL] [Abstract][Full Text] [Related]
38. Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats.
Munzar P; Laufert MD; Kutkat SW; Nováková J; Goldberg SR
J Pharmacol Exp Ther; 1999 Oct; 291(1):239-50. PubMed ID: 10490910
[TBL] [Abstract][Full Text] [Related]
39. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
Eison AS; Eison MS; Yocca FD; Gianutsos G
Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
[TBL] [Abstract][Full Text] [Related]
40. Role of 5-HT
Colmenares-Aguilar M; Lima L
Adv Exp Med Biol; 2017; 975 Pt 2():1129-1140. PubMed ID: 28849528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
